Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

PTC Therapeutics Inc. sell Citigroup Inc.

Start price
€17.60
27.10.23 / 50%
Target price
€16.10
27.10.24
Performance (%)
72.73%
Price
€30.40
26.07.24
Summary
This prediction is currently active. The SELL prediction by Citigroup_Inc_ for PTC Therapeutics Inc. is trending in the completely wrong direction and now has a performance of 72.73%. This prediction currently runs until 27.10.24. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
PTC Therapeutics Inc. 0.662% 0.662%
iShares Core DAX® 1.280% 1.027%
iShares Nasdaq 100 -2.457% -4.650%
iShares Nikkei 225® -2.006% -2.091%
iShares S&P 500 -0.662% -1.246%

Comments by Citigroup_Inc_ for this prediction

In the thread PTC Therapeutics Inc. diskutieren
Prediction Sell
Perf. (%) 72.73%
Target price 16.101
Change
Ends at 27.10.24

PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $17.00 price target on the stock, down previously from $29.00.
Ratings data for PTCT provided by MarketBeat

Stopped prediction by Citigroup_Inc_ for PTC Therapeutics Inc.

PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.40
21.05.24
€23.95
21.05.25
-12.99%
26.07.24